Mckesson Corp (NYSE:MCK) Institutional Investors Sentiment Change

September 30, 2018 - By Mary Kidd

McKesson Corporation (NYSE:MCK) Logo

Sentiment for Mckesson Corp (NYSE:MCK)

Mckesson Corp (NYSE:MCK) institutional sentiment increased to 1.05 in Q2 2018. Its up 0.15, from 0.9 in 2018Q1. The ratio increased, as 314 active investment managers increased and started new stock positions, while 300 sold and reduced their equity positions in Mckesson Corp. The active investment managers in our partner’s database now have: 172.34 million shares, down from 178.18 million shares in 2018Q1. Also, the number of active investment managers holding Mckesson Corp in their top 10 stock positions was flat from 12 to 12 for the same number . Sold All: 39 Reduced: 261 Increased: 238 New Position: 76.

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company has market cap of $26.50 billion. The firm operates in two divisions, McKesson Distribution Solutions and McKesson Technology Solutions. It currently has negative earnings. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community oncology and other specialty practices.

The stock increased 0.73% or $0.96 during the last trading session, reaching $132.65. About 1.17 million shares traded. McKesson Corporation (NYSE:MCK) has declined 16.67% since September 30, 2017 and is downtrending. It has underperformed by 32.29% the S&P500.

Analysts await McKesson Corporation (NYSE:MCK) to report earnings on October, 25. They expect $3.28 EPS, 0.00 % or $0.00 from last year’s $3.28 per share. MCK’s profit will be $655.26 million for 10.11 P/E if the $3.28 EPS becomes a reality. After $2.90 actual EPS reported by McKesson Corporation for the previous quarter, Wall Street now forecasts 13.10 % EPS growth.

Krensavage Asset Management Llc holds 11.05% of its portfolio in McKesson Corporation for 324,243 shares. Axon Capital Lp owns 60,912 shares or 10.44% of their US portfolio. Moreover, Taylor Asset Management Inc has 6.31% invested in the company for 102,100 shares. The Massachusetts-based Par Capital Management Inc has invested 6.27% in the stock. Ruffer Llp, a United Kingdom-based fund reported 1.22 million shares.

Since January 1, 0001, it had 0 insider buys, and 4 insider sales for $644,452 activity.

McKesson Corporation (NYSE:MCK) Ratings Coverage

Ratings analysis reveals 57% of McKesson’s analysts are positive. Out of 7 Wall Street analysts rating McKesson, 4 give it “Buy”, 0 “Sell” rating, while 3 recommend “Hold”. The lowest target is $142 while the high is $18600. The stock’s average target of $164 is 23.63% above today’s ($132.65) share price. MCK was included in 7 notes of analysts from April 11, 2018. Leerink Swann maintained the shares of MCK in report on Tuesday, May 29 with “Hold” rating. The firm earned “Buy” rating on Wednesday, April 18 by Cowen & Co. The firm has “Equal-Weight” rating by Morgan Stanley given on Tuesday, July 3. The company was upgraded on Tuesday, July 10 by Standpoint Research. The rating was maintained by Bank of America with “Buy” on Wednesday, April 11. The stock of McKesson Corporation (NYSE:MCK) earned “Overweight” rating by JP Morgan on Friday, July 27. On Friday, July 20 the stock rating was downgraded by Robert W. Baird to “Neutral”.

More news for McKesson Corporation (NYSE:MCK) were recently published by: Seekingalpha.com, which released: “McKesson’s Valuation From 3 Perspectives” on September 04, 2018. Seekingalpha.com‘s article titled: “McKesson: Good Enough To Be Great Value” and published on September 25, 2018 is yet another important article.

McKesson Corporation (NYSE:MCK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: